MusclePharm Corporation Share Price Other OTC

Stocks

18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
09/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
03/10/23	Motion for Asset Sale Approved for MusclePharm Corporation	CI
26/09/23	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
08/09/23	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
31/08/23	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
28/08/23	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
28/08/23	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
17/08/23	Bidding Procedure Approved for MusclePharm Corporation	CI
19/07/23	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
19/06/23	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
26/05/23	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
12/05/23	Motion for Asset Sale Filed by MusclePharm Corporation	CI

28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
29/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/09/22	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
23/08/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

1 day

+12.00%

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	30/09/2021
Jason Keenan PRN	Corporate Officer/Principal	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MUSCLEPHARM CORPORATION	+12.00%	+86.67%	-	-	33
EINRIDE AB	-0.79%	+5.43%	-	-	1.14B
CHURCHILL CAPITAL CORP XI	-3.78%	-10.55%	-	-	850M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.05%	+0.30%	-	-	643M
DEEP FISSION, INC.	+5.98%	+4.77%	-	-	663M
CHURCHILL CAPITAL CORP XII	-0.65%	-0.83%	-	-	609M
BAIN CAPITAL GSS INVESTMENT CORP.	0.00%	+0.05%	-	-	599M
CANTOR EQUITY PARTNERS IV, INC.	-0.10%	+0.19%	-	-	596M
CENTIEL AG	-2.70%	-6.45%	+253.66%	-70.56%	597M
Average	+1.11%	-1.20%	+253.66%	-70.56%	712.26M
Weighted average by Cap.	-0.38%	-0.89%	+253.66%	-70.56%